New blood test unveiled in Alberta for prostate cancer screenings
EDMONTON, AB – Nanostics Precision Health has created a new tool for screening prostate cancer.
Nanostics’ ClarityDX Prostate test is now available at its newly accredited clinical lab in Edmonton.
The blood test provides crucial support to men between the ages of 40 to 75, and it is able to determine with three times the accuracy of whether a biopsy is necessary following a high-prostate-specific antigen (PSA) test.
Dr. John D. Lewis, CEO of Nanostics and Bird Dogs Chair of Translational Oncology at the University of Alberta said, “This test will reduce the number of unnecessary prostate biopsies, which are invasive, uncomfortable, and carry some risk.”